IRF5 and neoplasm: Taken together these findings suggest two alternative scenarios: a) IRF5 might be inactivated due to point mutations or increased tyrosine phosphorylation as previously reported [22]; b) IRF5 might be either inducing the expression of tumor-promoting genes or inhibiting the promoters for tumor-suppressors.